180 related articles for article (PubMed ID: 33030015)
1. Aptamer Generated by Cell-SELEX for Specific Targeting of Human Glioma Cells.
Lin N; Wu L; Xu X; Wu Q; Wang Y; Shen H; Song Y; Wang H; Zhu Z; Kang D; Yang C
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9306-9315. PubMed ID: 33030015
[TBL] [Abstract][Full Text] [Related]
2. Evolution of Nucleic Acid Aptamers Capable of Specifically Targeting Glioma Stem Cells via Cell-SELEX.
Wu Q; Lin N; Tian T; Zhu Z; Wu L; Wang H; Wang D; Kang D; Tian R; Yang C
Anal Chem; 2019 Jul; 91(13):8070-8077. PubMed ID: 31179688
[TBL] [Abstract][Full Text] [Related]
3. Developing Aptamers by Cell-Based SELEX.
Catuogno S; Esposito CL; de Franciscis V
Methods Mol Biol; 2016; 1380():33-46. PubMed ID: 26552814
[TBL] [Abstract][Full Text] [Related]
4. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
5. Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging.
Wang L; Li P; Xiao X; Li J; Li J; Yang HH; Tan W
Talanta; 2018 Oct; 188():66-73. PubMed ID: 30029428
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide aptamers for glioma targeting: an update.
Camorani S; Cerchia L
Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
[TBL] [Abstract][Full Text] [Related]
7. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic applications of gastric carcinoma cell aptamers in vitro and in vivo.
Ding F; Guo S; Xie M; Luo W; Yuan C; Huang W; Zhou Y; Zhang XL; Zhou X
Talanta; 2015 Mar; 134():30-36. PubMed ID: 25618637
[TBL] [Abstract][Full Text] [Related]
9. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for
Zhang L; Zhou L; Zhang H; Zhang Y; Li L; Xie T; Chen Y; Li X; Ling N; Dai J; Sun X; Liu J; Zhao J; Peng T; Ye M
ACS Appl Mater Interfaces; 2021 Nov; 13(46):54656-54664. PubMed ID: 34779207
[TBL] [Abstract][Full Text] [Related]
10. A Highly Specific DNA Aptamer for RNase H2 from
Li J; Gu J; Zhang H; Liu R; Zhang W; Mohammed-Elsabagh M; Xia J; Morrison D; Zakaria S; Chang D; Arrabi A; Li Y
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9464-9471. PubMed ID: 33410654
[TBL] [Abstract][Full Text] [Related]
11. In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX.
Shi H; Tang Z; Kim Y; Nie H; Huang YF; He X; Deng K; Wang K; Tan W
Chem Asian J; 2010 Oct; 5(10):2209-13. PubMed ID: 20806314
[TBL] [Abstract][Full Text] [Related]
12. An aptamer-based, fluorescent and radionuclide dual-modality probe.
Zhang GX; Liu YL; Yang M; Huang WS; Xu JH
Biochimie; 2020; 171-172():55-62. PubMed ID: 32081705
[TBL] [Abstract][Full Text] [Related]
13. Advances in Aptamer-Based Biosensors and Cell-Internalizing SELEX Technology for Diagnostic and Therapeutic Application.
Gan Z; Roslan MAM; Abd Shukor MY; Halim M; Yasid NA; Abdullah J; Md Yasin IS; Wasoh H
Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354431
[TBL] [Abstract][Full Text] [Related]
14. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
[TBL] [Abstract][Full Text] [Related]
15. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
Zhong Y; Zhao J; Li J; Liao X; Chen F
Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
[TBL] [Abstract][Full Text] [Related]
16. A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy.
Zhang L; Wang M; Zhu Z; Ding C; Chen S; Wu H; Yang Y; Che F; Li Q; Li H
Int J Nanomedicine; 2021; 16():3217-3240. PubMed ID: 34007175
[TBL] [Abstract][Full Text] [Related]
17. Complex target SELEX.
Shamah SM; Healy JM; Cload ST
Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
[TBL] [Abstract][Full Text] [Related]
18. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
Shangguan D; Cao ZC; Li Y; Tan W
Clin Chem; 2007 Jun; 53(6):1153-5. PubMed ID: 17463173
[TBL] [Abstract][Full Text] [Related]
19. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
Delač M; Motaln H; Ulrich H; Lah TT
Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
[TBL] [Abstract][Full Text] [Related]
20. Aptamer Nanoconstructs Crossing Human Blood-Brain Barrier Discovered via Microphysiological System-Based SELEX Technology.
Choi JW; Seo M; Kim K; Kim AR; Lee H; Kim HS; Park CG; Cho SW; Kang JH; Joo J; Park TE
ACS Nano; 2023 May; 17(9):8153-8166. PubMed ID: 37068137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
